Abstract
Background Recent technological and radiological advances have renewed interest in using X-rays to screen and triage people with tuberculosis (TB). The miniaturization of digital X-ray (DXR), combined with automatic interpretation using computer-aided detection (CAD) software can extend the reach of DXR screening interventions for TB. This qualitative study assessed early implementers’ experiences and lessons learned when using ultra-portable (UP) DXR systems integrated with CAD software to screen and triage TB.
Methods Semi-structured interviews were conducted with project staff and healthcare workers at six pilot sites. Transcripts were coded and analyzed using a framework approach. The themes that emerged were subsequently organized and presented using the Consolidated Framework for Implementation Research (CFIR).
Results There were 26 interviewees with varying roles: supervisory, clinicians, radiographers, and radiologists. Participants recognized the portability as the main advantage, but criticize that it involves several compromises on throughput, internet dependence, manoeuvrability and stability, as well as suitability for patients with larger body sizes. Furthermore, compared to use the hardware and software from the same supplier without digital health information system, complexity increases with interoperability between hardware and software and between different electronic health information systems. Currently, there is a limited capacity to implement these technologies, especially due to need for threshold selection, and lack of guidance on radiation protection suitable for UP DXR machines. Finally, the respondents stressed the importance of having protected means of sharing patient medical data, as well as comprehensive support and warranty plans.
Conclusion Study findings suggest that UP DXR with CAD were overall well received to decentralize radiological assessment for TB, however, the improved portability involved programmatic compromises. Main barriers to the uptake included the insufficient capacity and lack of guidance on radiation protection suitable for UP DXR.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Global Affairs Canada funded the study through TB REACH for authors ZZQ and JC The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was approved and monitored by Ethikkommission der Medizinischen Fakultät Heidelberg (reference number: S-399/2021) in accordance with consensus ethical principles derived from international guidelines, including the Declaration of Helsinki (7th revision, 2013). The participants, all above 18 years of age, were informed that their participation in the study was voluntary, and that they could submit written or oral notification of withdrawal at any time, before or after the interview, without explanation or penalty. Written informed consent was obtained from all participants, with some wishing to be acknowledged as contributors and some remaining anonymous.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
Data cannot be shared publicly. The personal information of the participants and all other confidential information has been stored and secured according to the medical confidentiality and other provisions of the General Data Protection Regulation (GDPR), the German Federal Data Protection Act (BDSG) and the associated Baden-Württemberg State Data Protection Act (LDSG BW).